Pricing and Reimbursment
Following marketing authorization, the value of the ATMP is assessed to determine how it will be priced and reimbursed within healthcare systems. This process evaluates factors such as clinical benefit, unmet medical need, cost-effectiveness, and long-term patient outcomes to demonstrate the therapy’s value to patients and society. Successful pricing and reimbursement decisions are essential for enabling patient access and ensuring that the treatment can be adopted in clinical practice.
Health economics and patient access to ATMPs
This training gives you a picture of the methods for health economic evaluations as a basis for decisions about patient access to ATMPs. The course emphasizes the special characteristics that distinguish ATMPs compared to other drugs, which may require adjustments to the health economic calculations.
CCRM Nordic
CCRM Nordic, based in Gothenburg, Sweden, supports academic, small, and large industrial ATMP developers to translate research and early-stage clinical programs into treatments for patients.